Quercetin, a potent suppressor of NF-κB and Smad activation in osteoblasts

International Journal of Molecular Medicine

Volumn 28, Issue 4, 2011, Pages 521-525

  Yamaguchi, Masayoshi ^b   Weitzmann, M Neale ^a,b,c,d  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

NF B; Osteoblast; Osteoclast; Osteoporosis; Quercetin

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; I KAPPA B; LYMPHOTOXIN; OSTEOCLAST DIFFERENTIATION FACTOR; QUERCETIN; SMAD PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; MICE; NF-KAPPA B; OSTEOBLASTS; QUERCETIN; RANK LIGAND; SMAD PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79960751192     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.749     Document Type: Article

References (33)

1. Cheng WC, Huang RY, Chiang CY, et al: Ameliorative effect of quercetin on the destruction caused by experimental periodontitis in rats. J Periodontal Res 45: 788-795, 2010.
2. Hamalainen M, Nieminen R, Vuorela P, Heinonen M and Moilanen E: Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm 2007: 45673, 2007.
3. Nam NH: Naturally occurring NF-kappaB inhibitors. Mini Rev Med Chem 6: 945-951, 2006.
4. Weitzmann MN and Pacifici R: Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 116: 1186-1194, 2006.
5. Iotsova V, Caamano J, Loy J, Yang Y, Lewin A and Bravo R: Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 3: 1285-1289, 1997. (Pubitemid 27508833)
6. Xing L, Bushnell TP, Carlson L, et al: NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis. J Bone Miner Res 17: 1200-1210, 2002. (Pubitemid 34680496)
7. Vaira S, Johnson T, Hirbe AC, et al: RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation. Proc Natl Acad Sci USA 105: 3897-3902, 2008. (Pubitemid 351723496)
8. Boyce BF, Yao Z and Xing L: Functions of nuclear factor kappaB in bone. Ann NY Acad Sci 1192: 367-375, 2010.
9. Strait K, Li Y, Dillehay DL and Weitzmann MN: Suppression of NF-κB activation blocks osteoclastic bone resorption during estrogen deficiency. Int J Mol Med 21: 521-525, 2008. (Pubitemid 351802648)
10. Yamaguchi M and Weitzmann MN: Vitamin K2 stimulates osteoblastogenesis and suppresses osteoclastogenesis by suppressing NF-κB activation. Int J Mol Med 27: 3-14, 2011.
11. Yamaguchi M and Weitzmann MN: The estrogen 17β-estradiol and phytoestrogen genistein mediate differential effects on osteoblastic NF-κB activity. Int J Mol Med 23: 297-301, 2009.
12. Dai S, Hirayama T, Abbas S and Abu-Amer Y: The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J Biol Chem 279: 37219-37222, 2004. (Pubitemid 39195425)
13. Yamaguchi M, Hamamoto R, Uchiyama S and Ishiyama K: Effects of flavonoid on calcium content in femoral tissue culture and parathyroid hormone-stimulated osteoclastogenesis in bone marrow culture in vitro. Mol Cell Biochem 303: 83-88, 2007. (Pubitemid 47261304)
14. Woo JT, Nakagawa H, Notoya M, et al: Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts. Biol Pharm Bull 27: 504-509, 2004. (Pubitemid 41701834)
15. Wattel A, Kamel S, Mentaverri R, et al: Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption. Biochem Pharmacol 65: 35-42, 2003. (Pubitemid 35447836)
16. Wattel A, Kamel S, Prouillet C, et al: Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF-kappaB and AP-1. J Cell Biochem 92: 285-295, 2004.
17. Siddiqui JA, Sharan K, Swarnkar G, et al: Quercetin-6-C-beta-D- glucopyranoside isolated from Ulmus wallichiana planchon is more potent than quercetin in inhibiting osteoclastogenesis and mitigating ovariectomy-induced bone loss in rats. Menopause 18: 198-207, 2011.
18. Nanes MS: Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 321: 1-15, 2003.
19. Li Y, Li A, Strait K, Zhang H, Nanes MS and Weitzmann MN: Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic smad activation, through NF-kappaB. J Bone Miner Res 22: 646-655, 2007. (Pubitemid 351339092)
20. Yamaguchi M and Weitzmann MN: The bone anabolic carotenoids p-hydroxycinnamic acid and β-cryptoxanthin antagonize NF-κB activation in MC3T3 preosteoblasts. Mol Med Rep 2: 641-644, 2009.
21. Chang J, Wang Z, Tang E, et al: Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med 15: 682-689, 2009.
22. Alles N, Soysa NS, Hayashi J, et al: Suppression of NF-kappaB increases bone formation and ameliorates osteopenia in ovariectomized mice. Endocrinology 151: 4626-4634, 2010.
23. Wahl EC, Aronson J, Liu L, et al: Restoration of regenerative osteoblastogenesis in aged mice: modulation of TNF. J Bone Miner Res 25: 114-123, 2010.
24. Notoya M, Tsukamoto Y, Nishimura H, et al: Quercetin, a flavonoid, inhibits the proliferation, differentiation, and mineralization of osteoblasts in vitro. Eur J Pharmacol 485: 89-96, 2004. (Pubitemid 38134401)
25. Son YO, Kook SH, Choi KC, et al: Quercetin, a bioflavonoid, accelerates TNF-alpha-induced growth inhibition and apoptosis in MC3T3-E1 osteoblastic cells. Eur J Pharmacol 529: 24-32, 2006.
26. Nam TW, Yoo CI, Kim HT, Kwon CH, Park JY and Kim YK: The flavonoid quercetin induces apoptosis and inhibits migration through a MAPK-dependent mechanism in osteoblasts. J Bone Miner Metab 26: 551-560, 2008.
27. Prouillet C, Maziere JC, Maziere C, Wattel A, Brazier M and Kamel S: Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem Pharmacol 67: 1307-1313, 2004. (Pubitemid 38315096)
28. Yamaguchi M and Weitzmann MN: The bone anabolic carotenoid β-cryptoxanthin enhances transforming growth factor-β1-induced SMAD activation in MC3T3 preosteoblasts. Int J Mol Med 24: 671-675, 2009.
29. Sugimoto E and Yamaguchi M: Anabolic effect of genistein in osteoblastic MC3T3-E1 cells. Int J Mol Med 5: 515-520, 2000.
30. Siddiqui JA, Swarnkar G, Sharan K, et al: A naturally occurring rare analog of quercetin promotes peak bone mass achievement and exerts anabolic effect on osteoporotic bone. Osteoporos Int: Jan 12, 2011 (Epub ahead of print).
31. Janssens K, Ten Dijke P, Janssens S and Van Hul W: Transforming growth factor-beta1 to the bone. Endocr Rev 26: 743-774, 2005.
32. Canalis E, Economides AN and Gazzerro E: Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24: 218-235, 2003. (Pubitemid 36515285)
33. Phan TT, Lim IJ, Chan SY, Tan EK, Lee ST and Longaker MT: Suppression of transforming growth factor beta/smad signaling in keloid-derived fibroblasts by quercetin: implications for the treatment of excessive scars. J Trauma 57: 1032-1037, 2004. (Pubitemid 39579289)